Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2026 02:30 ET | Source: Custom Market Insights

[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, June 26, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “In Silico Clinical Trials Market Size, Trends and Insights By Component...
June 25, 2026 13:30 ET | Source: Custom Market Insights

[Latest] Global Bioprocess Digital Twin Market Size/Share Worth USD 6.47 Billion by 2035 at a 19.6% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, June 25, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Bioprocess Digital Twin Market Size, Trends and Insights By Component...
June 25, 2026 04:30 ET | Source: Custom Market Insights

Global Cell Therapy Human Raw Materials Market Size/Share Worth USD 18.94 Billion by 2035 at a 16.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Austin, TX, USA, June 25, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Cell Therapy Human Raw Materials Market Size, Trends and Insights By Product Type...
June 24, 2026 16:30 ET | Source: Custom Market Insights

[Latest] Global Stem Cell Culture Media Market Size/Share Worth USD 2714 Million by 2035 at a 13.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, June 25, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Stem Cell Culture Media Market Size, Trends and Insights By Type (Mesenchymal...
June 17, 2026 16:15 ET | Source: Odyssey Therapeutics Inc

Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reported positive clinical proof-of-concept data for OD-001 in a Phase 2a monotherapy trial for moderate to severe ulcerative colitis.
June 11, 2026 06:52 ET | Source: Quetzal Therapeutics

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia

CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare hematologic malignancies, today announced that the first patient...
June 11, 2026 06:30 ET | Source: Custom Market Insights

Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Austin, TX, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Next Generation Sequencing Services Market Size, Trends and Insights By Service...
June 10, 2026 12:03 ET | Source: Teva Pharmaceutical Industries Ltd

Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy

Ecopipam, an investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan Drug...
June 03, 2026 08:30 ET | Source: Liminatus Pharma Inc.

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
May 27, 2026 09:00 ET | Source: AsymBio

AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates

AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation technologies.For IND-enabling programs, conjugation process development timelines...